Skip to main content

Animations

MJFF Publications

5271 - 5280 of 8823 Results
Title
Year
  • Year
  • 2020
  • 2025
  • 2025
  • 2024
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: Shared Genetics of Multiple System Atrophy and Inflammatory Bowel Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28338
    Citation Count: 21
  • Summary Details
    RESTRICTED
    Title: Frailty in prodromal Parkinson's disease in Medicare beneficiaries
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107965
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41467-025-56293-z
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Exome sequencing in Asian populations identifies low-frequency and rare coding variation influencing Parkinson’s disease risk
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s43587-024-00760-7
    Citation Count: 14
  • Summary Details
    RESTRICTED
    Title: Lasmiditan ameliorates cortico-hippocampal pathology and improves cognition in aging parkinsonian mice
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2025.115502
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Peripheral Immune pattern in a genetic cohort of p.A53T alpha-synuclein carriers
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107853
    Citation Count: 1
  • Summary Details
    OPEN
    Title: LRRK2 rare-variant per-domain genetic burden in Parkinson’s Disease: association confined to the kinase domain
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00934-z
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Four questions to predict cognitive decline in de novo Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00958-5
    Citation Count: 1
  • Summary Details
    OPEN
    Title: The role of alpha-synuclein in synucleinopathy: Impact on lipid regulation at mitochondria–ER membranes
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00960-x
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Relationships between neuropsychiatric symptoms, subtypes of astrocyte activities, and brain pathologies in Alzheimer's disease and Parkinson's disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.70242
    Citation Count: 3
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.